Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.79 USD | +2.00% | 0.00% | -29.46% |
May. 20 | Bolt Biotherapeutics, Inc. Announces Management Changes | CI |
May. 20 | Bolt Biotherapeutics, Inc. Announces Chief Executive Officer Changes | CI |
Financials (USD)
Sales 2024 * | 8.5M | Sales 2025 * | 19.94M | Capitalization | 30.12M |
---|---|---|---|---|---|
Net income 2024 * | -45M | Net income 2025 * | -47M | EV / Sales 2024 * | -19.5 x |
Net cash position 2024 * | 196M | Net cash position 2025 * | 244M | EV / Sales 2025 * | -10.7 x |
P/E ratio 2024 * |
-0.63
x | P/E ratio 2025 * |
-0.84
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.53% |
1 day | +2.00% | ||
Current month | -28.51% | ||
1 month | -28.83% | ||
3 months | -34.17% | ||
6 months | -15.04% | ||
Current year | -29.46% |
Managers | Title | Age | Since |
---|---|---|---|
William Quinn
CEO | Chief Executive Officer | 53 | 20-04-30 |
John Tomaro
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Priti Hegde
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Miller
BRD | Director/Board Member | 73 | 17-06-30 |
Mahendra Shah
BRD | Director/Board Member | 79 | 16-08-31 |
James Healy
BRD | Director/Board Member | 59 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.79 | +2.00% | 562,369 |
24-05-23 | 0.7745 | +1.24% | 387,123 |
24-05-22 | 0.765 | -1.29% | 511,504 |
24-05-21 | 0.775 | -1.90% | 429,687 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.46% | 30.12M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.19% | 22.1B | |
-8.31% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- BOLT Stock